EMEA-000245-PIP01-08-M06

Key facts

Invented name
Amitiza
Active substance
Lubiprostone
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0363/2019
PIP number
EMEA-000245-PIP01-08-M06
Pharmaceutical form(s)
Capsule, soft
Condition(s) / indication(s)
Treatment of constipation
Route(s) of administration
Oral use
Contact for public enquiries
Sucampo AG

E-mail: medinfo@mnk.com
Tel.  +800 55444777

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating